Silence Therapeutics Plc logo

SLN

Silence Therapeutics Plc

$23.46

Earnings Summary

Revenue
$2.8Mn
Net Profits
$-8.25Mn
Net Profit Margins
-294.85%

Highlights

Revenue:

Silence Therapeutics Plc’s revenue fell -17% since last year same period to $2.8Mn in the Q3 2023. On a quarterly growth basis, Silence Therapeutics Plc has generated -69.27% fall in its revenue since last 3-months.

Net Profits:

Silence Therapeutics Plc’s net profit fell -16.15% since last year same period to $-8.25Mn in the Q3 2023. On a quarterly growth basis, Silence Therapeutics Plc has generated 20.68% jump in its net profits since last 3-months.

Net Profit Margins:

Silence Therapeutics Plc’s net profit margin fell -39.93% since last year same period to -294.85% in the Q3 2023. On a quarterly growth basis, Silence Therapeutics Plc has generated -158.09% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Silence Therapeutics Plc post its latest quarter earnings

EPS Estimate Current Quarter
-0.11
EPS Estimate Current Year
-0.11

Highlights

EPS Estimate Current Quarter:

Silence Therapeutics Plc’s earning per share (EPS) estimates for the current quarter stand at -0.11 - a -47.04% fall from last quarter’s estimates.

EPS Estimate Current Year:

Silence Therapeutics Plc’s earning per share (EPS) estimates for the current year stand at -0.11.

Key Ratios

Key ratios of the Silence Therapeutics Plc post its Q1 2024 earnings

Earning Per Share (EPS)
0

Highlights

Earning Per Share (EPS):

Silence Therapeutics Plc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the Silence Therapeutics Plc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-14
-0.11
0
100%